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Implementation of the Department of Health Research
Governance Framework (RGF) in the United Kingdom
has major implications for the conduct of pharmacy
practice undergraduate research projects. This paper
draws upon a survey of local ethics research committees
(LRECs) in the greater Birmingham area to identify the
issues that arise from the RGF in relation to non-clinical
practice research in community pharmacy. Although
there is some evidence of minor differences between
LRECs, the overwhelming finding is that projects will
be subject to the full force of the RGF. The implications
are discussed in relation to specific issues relating to
non-clinical research, the professional aspirations for a
research capable workforce, and the expertise within
pharmacy to meet the current accreditation requirements
for undergraduate projects.
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INTRODUCTION
The Research Governance Framework for Health
and Social Care
United Kingdom Department of Health (DOH)
guidance on research governance (Department of
Health, 2001a) is currently having a dramatic impact
on our approach to undergraduate research in our
School of Pharmacy. This paper addresses the very
topical issue of research ethics and undergraduate
education since our experiences are being mirrored in
all other schools of pharmacy in England and Wales.
For many years it was expected that research
involving National Health Service (NHS) patients,
staff or premises should receive the prior approval of
a Local Research Ethics Committees (LREC) (Jesson,
1997). However, the non-NHS status of community
pharmacy meant that many researchers undertook
non-clinical pharmacy practice research, particularly
at undergraduate level, without recourse to an NHS
ethics committee. It is very clear from the abstracts of
past Health Service Research and Pharmacy Practice
Conferences (HSR/PP) and British Pharmaceutical
Conferences (BPC) that undergraduate work has
been an important element in advancing the
evidence base of pharmacy practice. This contribu-
tion is now threatened by the DOH Research
Governance framework (Department of Health,
2001b), which complements clinical and corporate
governance guidance, and requires all health projects
to be approved by an appropriate LREC (not just a
university ethics committee).
As researchers we have always been aware of the
importance and relevance of research ethics commit-
tee approval when carrying out research which
involves the NHS and which is clinical or which
involves medical practitioners or patients’ medical
records. Such work has normally been associated
with major research projects such as commissioned
research (Wilson et al., 2002). The new framework has
a number of objectives mainly concerned with
quality and responsibility and it is intended to
have wide applicability (Fig. 1). A stated priority is
that it “pays particular attention to clarifying
responsibilities and accountabilities”.
The Royal Pharmaceutical Society of Great
Britain (RPSGB) as a research funder has already
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incorporated the guidance to ensure that all
pharmacy practice research it funds has LREC
approval. Although the process and procedures
for such approval are not new, there are three
new elements and these are described in numerous
DOH research governance documents:
1. the issue of quality,
2. the inclusion of community pharmacy,
3. the inclusion of undergraduate research.
We begin by summarising the key issues in the
new guidance, describe the results of a survey of
guidance given by our local Research Ethics
Committees and then discuss the implications as
we see them for our own pharmacy research practice.
When do We need Ethical Approval from NHS
Research Ethics Committees (REC)?
The new Research Governance Framework (RGF)
(Department of Health, 2001b) reinforces all previous
DOH advice on research. In this context, research is
defined (section 1.7) as ”the attempt to derive
generalisable new knowledge by addressing clearly
defined questions with systematic and rigorous
methods”.The framework applies to all research
carried out in or by the NHS in England and Wales,
including joint projects undertaken with universities,
pharmaceutical companies, charities and research
councils (Fig. 2). Thus the remit of an NHS LREC is
wide and the guidance to LRECs, “Governance
Arrangements for NHS Research Ethics Commit-
tees” (Department of Health, 2001a), makes
explicit reference to undergraduate student projects
(section 10.4). This shows little compromise stating,
“Research to be undertaken by students primarily
for educational purposes (e.g. as a requirement for a
University degree course) shall be considered
according to the same ethical and operational
standards as are applied to other research. In such
cases the supervisor takes on the role and respon-
sibilities of the sponsor. In reaching its decision, the
REC will wish to consider the broader overall
benefits gained by such research.”
We return to discuss the ambiguity of the place of
pharmacy in the NHS later. But it is difficult to
envisage how we might undertake any meaningful
pharmacy undergraduate HSR in the future without
having LREC approval. The next section describes
the academic pharmacy context of the undergradu-
ate research project.
The Pharmacy Context: Education and Professional
Accreditation
The pharmacy and education context is set by the
RPSGB requirements for degree accreditation,
revised 2002 (Royal Pharmaceutical Society of
Great Britain, 2002). These must accord with a
European Union (EU) directive (85/432/EEC) on
pharmacy education which provides general
FIGURE 1 The DOH (4.RGF: p2) core objectives in launching the new guidance.
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requirements in relation to syllabus. This directive
makes no reference to an undergraduate project
but there is a 1994 recommendation from the EU
Advisory Committee on Pharmaceutical Training
that “each student should carry out a personally
directed research project covering about three to six
months under the supervision of the academic staff
and present a paper or dissertation on the project”.
This recommendation has been encapsulated
within the RPSGB accreditation specifications that
make an undergraduate research project a specific
requirement and that also provide a limited
definition of the project in terms of student workload
and activities (Fig. 3).
Although the project is obligatory, the RPSGB
criteria that define graduate qualities and the
pharmacy undergraduate degree make little refer-
ence to research and the only outcome criteria
linking research with graduate capability is that
graduates should be able to “apply appropriate
research approaches and methods to manage
scientific and practice problems”. This level of
capability is, however, in accord with the aim
articulated within the report of the Mays Taskforce
on pharmacy practice research (Royal Pharma-
ceutical Society of Great Britain, 1997) that 100% of
pharmacists should be “research users”.
Whilst fulfilling the RPSGB undergraduate curri-
culum requirements, our educational aim as a school
of pharmacy is that the compulsory research project
should be a true learning experience for the student.
For our own personal and professional development
we want as staff to work with our undergraduates to
produce good quality research, which is interesting,
meaningful and from which we can all benefit. In our
particular cases, we also want to add to the evidence
base of pharmacy practice. This we achieve through
dissemination of the research findings, an activity
that has been successful for several years now.
This includes the discussion of research issues at
FIGURE 2 The Remit of an NHS REC (Governance arrangements for NHS Research Ethics Committees: 7).
FIGURE 3 RPSGB accreditation criteria 5—the requirement for an undergraduate research projects.
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conferences, not just within pharmacy at the HSR/PP
and BPC, but also outside the profession at the
British Sociological Association (BSA Medsoc),
and UK Public Health Forum (UKPHA). As a
consequence students benefit from the promotion
of their work and gain the advantage of publication
in their name.
In our school it is an educational aim that students
must address within their project each of the core
research process components shown in Fig. 4. It is,
therefore, inappropriate for the research supervisors
to design the project and the research instruments
since this would mean using the students as research
assistants with a reduction in their learning. Our own
projects are firmly based in the social sciences
methodology and techniques, not in clinical inter-
ventions. Up until now we did not believe it to be
appropriate to submit undergraduate research
projects to LRECs since they are learning vehicles,
they are pharmacy or service based and not clinical
interventions, they do not involve NHS staff but are
focussed upon either process or upon the views and
experiences of general members of the public.
The main difference between our core process
tasks and the RPSGB guidance is that the latter does
not refer to performance of research, fieldwork or the
design and development of the research method.
Whilst the RPSGB focus upon critical evaluation of
the method and interpretation of results will develop
research awareness, it has always been our
educational aim to support attainment of the aim in
the Mays Report (Royal Pharmaceutical Society of
Great Britain, 1997) that 10% of pharmacists become
“research practitioners” and 1% “research leaders”.
In our school, projects take place in the second
term (10 weeks) of the final undergraduate year with
selection of titles by the students during the first
term. The new research framework, therefore, has
major implications since all research instruments
must be submitted to the LREC at the time of
approval. It appeared that to meet our educational
objectives and the needs of the approval process
there would need to be a major rescheduling of the
process.
Before making any significant changes in our
approach we sought advice from the relevant LRECs,
using contact addresses listed on the DOH website
for the region. The aim of the survey was to seek
clarification and make some negotiation on the best
way forward to manage undergraduate community
pharmacy projects.
METHODS
Letters describing our research programme and
concerns about timescales were posted to the nine
West Midlands LRECs, in preference to e-mail or
telephone, in mid-October 2002. The letter made
clear that the nature of the research was not clinical
and would not involve access to confidential patient
records or affect therapy. We described four broad
themes of work based upon our own recent research
programme and chosen to reflect HSR rather than
clinical research:
. primary care pharmacist (functions, responsi-
bilities, educational needs)
. electronic transfer of patient data (policy, patient
and prescriber views)
. services to drug misusers in the community
(management of services, nature, needs analysis)
. health centre pharmacies (service development,
patient and health professional views).
Replies were received from five of the nine by
January 2003. A follow up letter was posted to the
four non-responders in mid February 2003. A further
two replies were received by March, leaving two
outstanding.
FIGURE 4 Core research process tasks in the undergraduate project.
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Following analysis of the replies, a further
communication was made by letter to the Primary
Care Trust (PCT) Research Administrator, in March.
The six months that passed in attempting to clarify
our position says a lot about the administrative
capability of the LRECs, and an apparent lack of
urgency demonstrated by respondents.
RESULTS
The written responses varied in the quality and
amount of information supplied to us by the eight
LRECs. Only one explained that changes were still
taking place and that the committees hope to have
their procedures put into practice by October 2003.
This does help us to understand the slow responses
as a consequence of an “organisational flux” context.
We report in particular on: general advice given,
issues of research process management, particularly
the confirmation of LREC approval, the time scales
involved, methods and sampling.
General Advice
Whilst one respondent just enclosed their standard
letter and documentation for the LREC and Multi-
centre Research Ethics Committees checklists with-
out comment to our query(s), most of the others
made reference to the DOH website, the Governance
Arrangements for NHS Research Ethics Committees
documentation quoting the relevant paragraphs
three and ten and to a named contact at the
Central Office for Research Ethics Committees for
further queries. All respondents confirmed that we
must have all research reviewed by a LREC. Some
were more sympathetic to our particular problems
than others.
“I fully appreciate the problems that you allude to, they are
exactly the same problems faced by medical students”(A-1).
“There is no shortcut, if students are to gain an
understanding or insight into conducting research an
application to the REC is integral to the process ” (B-2)
“REC procedures are in place to safeguard patients and staff
and apply equally to student’s projects, although
unfortunately their applications are often of a low
standard” (B-3)
Time Scales
Most LRECs met monthly, one advised of bi-monthly
meetings. In general respondents stressed that the
responsibility to meet the imposed timetable rested
with the project supervisor. This reinforced the
message that student projects will be treated as any
other piece of work.
“The way to get a quick answer is to get the documentation
correct first time round”, (C-1)
“The safest way forward is for your students to submit their
projects to us for the first six months, so that we can judge
whether it is in fact necessary for student research projects to
come to the Committee” (A-2).
“Increase the lead in time provided by the University” (B-4)
“I note your concerns regarding short timescales for project
modules, at present the REC holds bi-monthly meetings—if
urgent need for approval may give provisional approval”
(D-1)
“I understand the timescales but suggest careful planning ”
(E-1)
Approaches to Methodology and Sampling
Our letter made reference to the use of surveys
to determine the views of patients and health
professionals. The responses were inconsistent.
One LREC was clearly uncertain as to the nature of
pharmacy practice research but expressed the view
that any questionnaire would need to be reviewed.
“There may be some difference in the pharmacy
undergraduate research project (compared with medicine)
if they do not utilise patients or do not use patient
questionnaires ” (A-3)
“If there is any suggestion that pharmacy undergraduates
will be using questionnaires, either to ask NHS staff
or patients, they will certainly need to come to committee”
(A-4)
Another LREC distinguished between “patients”
and “members of the general public” on the basis of
the purpose of the study while a third stated more
broadly that patient satisfaction surveys would not
require approval.
“Questionnaires should always be submitted if they address
anyone in their status as patient, relative or carer. This
includes, for example, “members of the public” approached
through general practitioners, but not those approached in a
shopping centre, nor questionnaires to other students, for
both of which school/department review procedures should
be developed” (E-2)
“In general patient satisfaction survey would not require
ethical approval unless they were asking sensitive or
personal questions of patients” (B-5)
One response also raised the issue of the
distinction between audit and research.
“If the committee judges them to be audit rather than
research they will reply accordingly” (E-3)
New Structures—Pharmacy and the Primary Care
Trust (PCT)
Primary Care Trusts are local health organisations
responsible for managing local health services, PCTs
work with local authorities and other agencies that
provide health and social care locally to make sure
the community’s needs are being met.
Probably the most useful and important new
information about pharmacy came from one LREC
who noted that under the RGF (2001) (Department of
Health, 2001b) responsibility for research is shared
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by the Research and Development department
in Trusts. The LREC had itself received communica-
tions from the Research and Development
manager of one of the four Birmingham Primary
Care Trusts, which has overall management respon-
sibility for research over Birmingham. As part of the
clinical governance arrangements, research must
receive approval from this source following approval
by an LREC. The advice from the research manager
with respect to the position of community pharmacy
was explicit:
“Community pharmacists come under the remit of the
PCT therefore all ongoing research within the community
setting needs to be registered with me—the PCT has a duty
of care to its patients and for that reason we need to be aware
of the projects”
DISCUSSION
In its degree accreditation specification, the UK
statutory regulator for pharmacy makes a specific
requirement for a final year research project (Royal
Pharmaceutical Society of Great Britain, 2002). In our
own School of Pharmacy there has been a steady
increase in the popularity of practice related projects
to the point that these now account for around one
third of all projects. Therefore the introduction of the
new NHS RGF (Department of Health, 2001b) is of
very direct relevance to undergraduate pharmacy
education. As has been explained, our interest and
the subject of this paper is the area of non-clinical
pharmacy practice research. Our study has shown
that there is national guidance, but maybe some
variation at local level in interpretation over subjects
and methods. Much of the variation of opinion
appeared to be due to a lack of familiarity with
community based pharmacy practice research and
the nature of community pharmacy.
The Ambiguity of Pharmacy, Public and Market
Research
We would argue that there are still some funda-
mental problems for implementing research govern-
ance within the pharmacy undergraduate research
project. The three most important concepts for
us are the nature of community pharmacy,
the role of the general public in relation to
community pharmacy and the scope of research
within community pharmacy.
Firstly, in the case of pharmacy, community
pharmacies (the premises) are private sector organ-
isations delivering a service to the NHS under
contract. They operate in a competitive retail
environment and pharmacists are private sector
not NHS employees. Much of the research on
activities and services within the sector does not
involve confidential information or clinical matters.
As such it appears to us that it is arguable
whether such research is covered by the terms of
the NHS RGF. In this respect the apparent role of
the PCT research and development manager in
approving research in the community sector is of
interest. Whilst there is a clear clinical governance
issue in relation to research carried out within the
NHS funded PCTs, it is less clear that an NHS funded
management has a similar responsibility within
private contracted organisations such as community
pharmacies.
Secondly, there is the concept of patients as distinct
from the general public. It is clear that members of
the public as patients within an NHS setting are
covered by the research framework, but this is less
clear when we are conducting research with
members of the public in their capacity as pharmacy
customers or users of pharmacy services. The varied
guidance given by our LREC replies recognise this
inconclusiveness.
The above arguments come together when
considering the nature of research carried out in
community pharmacy. The companies that operate
community pharmacies must undertake market
research to maintain their position within an
increasingly commercial retail sector. There is clearly
overlap between this and pharmacy practice
research with a major difference that external
practice research, as undertaken in student projects,
is intended to be made public. From our previous
communications with and involvement in private
sector research, we believe that it is highly unlikely
that market research undertaken by the pharmacy
multiples will be submitted to LRECs. Similarly,
it seems probably that the major pharmaceutical
companies will presumably also continue to do their
own market research within general practice under
without reference to LREC approval. We would
argue that there should be consistency in the
application of the research ethics framework based
upon the nature of the research.
Implications within Pharmacy Practice: Quality
and Capacity?
Notwithstanding the conceptual ambiguity, the new
research framework has significant implications for
undergraduate research within schools of pharmacy.
It is clear from the responses that we received that
there is no compromise in respect of undergraduate
project work. Research to be undertaken by students
primarily for education purposes, even though
often of limited scope, will be considered with the
same ethical rigour and operational standards
as are applied to other research. This poses the
schools of pharmacy with a double challenge:
ensuring the quality of the research and the capacity
to supervise it.
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Within each student cohort there are variable
levels of capability and skills. Educationally, a
primary aim of the project is to develop and improve
research capability during the course of the module.
Yet the RFG minimum requirements of research
governance systems demands absolute standards
at the outset and place the responsibility upon the
research sponsor (Department of Health, 2001b):
. “The research proposal must be worthwhile, of
high scientific quality and represent good value
for money” (RGF 3.8.6)
. “The arrangements and resources proposed will
allow the collection of high quality, accurate data”
(RGF 3.8.6)
. “Research which duplicates other work
unnecessarily or which is not of sufficient quality
to contribute something useful to existing
knowledge is itself unethical” (RGF 2.3.1. 12)
One LREC recognised our concern about
standards. Final year students have to submit their
own research design to a professional audience for
approval prior to implementation, yet have not had
time to develop such skills. Furthermore, the
research framework requires that as active member
of the research team (a researcher); students must
have demonstrable research capability:
“Each member of the research team is qualified by education,
training and experience to discharge his/ her role in the
study” (RGF 3.6.3:25)
The ability to improve pharmacist capability is
therefore dependent upon the capabilities of the
academic supervising staff, and their ability to
ensure that the student and the research meet
LREC standards. Implementation of the RGF places
enormous demands upon staff. In the case of student
projects, the internal staff member, as the project
supervisor, assumes the obligations as sponsor of
the research and therefore the overall responsibility
for ensuring compliance with the framework
(Department of Health, 2001a). In most cases, the
supervisor will also be the principal investigator and
must, therefore, assume a range of specific respon-
sibilities detailed in section 3.6 of the framework
(Department of Health, 2001b):
“The principal investigator must have the necessary
expertise and experience to conduct the proposed research
successfully”
“Principal investigators must have suitable experience and
expertise in the design and conduct of research so that they
are able either to undertake the design, conduct, analysis and
reporting of the study to the standards set out in this
framework or to lead and manage others”
In our view this raises another dilemma.
We appreciate that this critique will not be
well received by many, but pharmacy practice
research is a discipline which is relatively new
(Nuffield Foundation, 1986) and, from our joint
personal experience of 14 years in the practice
research community, has had to struggle to meet
acceptance within the pharmacy academic pro-
fession. The RPSGB Workforce survey showed that
only 5% of the pharmacy profession has a Ph.D., 15%
a Diploma. 43% of those who work in academia
have a Ph.D. (Hassell and Shann, 2003). Application
of the RGF to the final year project changes the
nature of the exercise from a learning process to a full
scale piece of research. It is not clear that there is the
research capability within the schools of pharmacy,
let alone the profession, to support this.
Moreover, the capacity of LRECs themselves to
cope with all student projects in the area
is questionable. In Birmingham we have three
universities, which produce an annual output of
pharmacists, doctors, nurses and other professions
allied to medicine. Then there is the capability of the
members of LRECs themselves, many still based in
secondary care locations, consisting of clinical
professionals, who in the past had difficulty relating
to primary care, health services and social science
based research studies. This observation is based on
our own experience and the frequent outpouring
of communications within the medical press
about the shortcomings of the quality of decisions
(Nicholl, 2000; Lyon, 2002). Assessing hundreds of
undergraduate projects each year is not an efficient
or cost effective use of LREC resources. None of the
student projects will involve patient harm, clinical
intervention or fraud.
The Way Forward
From a university perspective there are practical
changes that we have to make, to comply with the
research framework. We probably have until March
2004 when all active NHS care organisations should
comply with the RGF, to reorganise the project
module. First there is the issue of time tabling and
time scales, which the LREC responses recognised.
In our own school, the final year project takes place
over ten weeks in second term of the fourth year.
If we must have prior approval for anything other
than very simple attitudinal student based sampling,
then that cannot continue. One possibility is to
split the project over two terms and to teach research
proposal and research instrument design early in the
first term, and then carry out the project in half of the
second term. This would have major implications for
other subject timetabling for the whole year cohort
but most importantly, it raises the question as to how
to proceed if a students submit a proposal in the first
term and the LREC asks for a redesign or issues a
rejection. Furthermore, what does that often brutally
worded rejection do to student confidence?
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There are, however, wider implications. From an
educational perspective, we think that the RPSGB
needs to reconsider the requirement that all students
complete an “extended” undergraduate research
project. This is articulated in criteria five of the
accreditation document (Royal Pharmaceutical
Society of Great Britain, 2002) and it is stated
to be a pre-requisite dictated by EU requirements.
However, the origin of this requirement is not the
primary EU directive on Pharmacy Education,
directive 85/432/EEC, but instead it is one of a
number of recommendations made in 1994 by an EU
Advisory Committee on Pharmaceutical Training,
itself set up under directive 85/434/EEC. These
recommendations are now almost a decade old and
were made in a different educational and funding
climate and prior to the DOH RGF and the many
issues that lead to it such as the debate on
professional responsibility in the wake of the Bristol
Heart Review (Bristol Royal Infirmary Inquiry, 2001).
In our view, the key question is as to the purpose of
the project. Criteria five of the RPSGB accreditation
document specifies that the project must “address a
research question or a problem, must involve a
critique of the research methodology employed, and
must include an analysis of results generated directly
by the student or indirectly by others as primary
researchers”. There is, therefore, apparently no
requirement for the student to plan the research, to
design the research methods or to undertake the
research—field work in a pharmacy practice context.
Furthermore, the only criterion on graduate
competencies that addresses research, criteria 21,
merely states that the graduate “can apply
appropriate research approaches and methods to
manage scientific and practice problems”. In the
context of the Mays report on pharmacy practice, this
appears to equate to the lowest level, the “research
user.” This is appropriate as an objective for all
students but as educationalists we have always
regarded the project as a key element in the
development of “research practitioners” and there-
fore of future “research leaders”. There are many
ways of developing research awareness but not, we
would argue, of engendering research practitioners.
In the increasingly restrictive research governance
environment, there appears to us to be a need
to review the intended purpose of the project
and therefore the requirement that all students
undertake a project.
Finally, we believe that this new tension between
research governance and risk management of clinical
research has reinforced the level of bureaucratic
social control that an unaccountable body will have
over schools of pharmacy and pharmacy practice
research. We predict that it will destroy innovation
and stifle creativity in pharmacy practice, as staff
may choose projects that are mainly literature reviews
and student sample based studies. Most important of
all though is our belief that far from setting new
standards for HSR, protecting participants in
research, and improving the quality of research, the
new framework will limit the student experience and
make it more difficult to develop practitioners who
will be the future research leaders.
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